Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AZN | AMGN | GILD | VRTX |
| Company | Cara Therapeutics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.39 | 72.52 | 289.44 | 105.33 | 500.79 |
| High | 5.52 | 72.57 | 290.99 | 105.65 | 507.57 |
| Low | 5.28 | 71.30 | 286.09 | 103.80 | 497.34 |
| Last | 5.32 | 71.69 | 289.12 | 105.11 | 505.95 |
| Change | -0.23 | -0.02 | +0.56 | +0.90 | +2.45 |
| % Change | -4.14% | -0.03% | +0.19% | +0.86% | +0.49% |
| Volume | 237,100 | 1,641,263 | 790,818 | 3,376,554 | 427,146 |
| 20-Day Average Volume | 30,465 | 7,016,042 | 3,078,045 | 9,706,177 | 1,634,127 |
| Previous Close | 5.55 | 71.71 | 288.56 | 104.21 | 503.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.16 | 68.47 | 286.93 | 105.66 | 487.77 |
| 20-Day Raw Stochastic | 65.04% | 71.51% | 45.20% | 54.05% | 98.01% |
| 20-Day Relative Strength | 54.57% | 52.78% | 47.49% | 47.60% | 58.41% |
| Weighted Alpha | -27.45 | -6.27 | -7.97 | +56.37 | +24.01 |
| Today's Opinion | 100% Buy | 24% Sell | 40% Sell | 40% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 24% Sell | 40% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 72% Buy | 8% Buy | 32% Buy | 100% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.69% since 04/08/25 | +4.48% since 04/23/25 | +3.95% since 04/23/25 | -1.37% since 04/23/25 | +2.84% since 04/23/25 |
| Low | 4.71 on 04/09/25 | 68.48 on 04/24/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 484.50 on 04/25/25 |
| High | 5.75 on 04/14/25 | 72.57 on 04/30/25 | 290.76 on 04/30/25 | 107.56 on 04/24/25 | 507.57 on 04/30/25 |
| 1-Month | |||||
| %Chg | +3.70% since 03/14/25 | -2.99% since 03/28/25 | -5.89% since 03/28/25 | -6.14% since 03/28/25 | +2.78% since 03/28/25 |
| Low | 4.52 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 5.75 on 04/14/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 507.57 on 04/30/25 |
| 3-Month | |||||
| %Chg | +19.28% since 01/15/25 | +0.48% since 01/30/25 | +1.71% since 01/30/25 | +8.23% since 01/30/25 | +15.51% since 01/30/25 |
| Low | 4.30 on 03/05/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 446.00 on 02/12/25 |
| High | 6.00 on 01/27/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +73.86% since 10/15/24 | -1.72% since 10/30/24 | -8.45% since 10/30/24 | +18.84% since 10/30/24 | +6.59% since 10/30/24 |
| Low | 2.71 on 12/18/24 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 6.36 on 12/31/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 24,332 | 222,390,416 | 155,144,576 | 129,758,432 | 129,440,280 |
| Shares Outstanding, K | 4,574 | 3,101,247 | 537,651 | 1,245,163 | 257,081 |
| Annual Sales | 7,140,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -70,870,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,460,000 | 14,891,000,000 | 9,086,000,000 | 6,667,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -7,680,000 | 1,499,000,000 | 627,000,000 | 1,315,000,000 | 913,000,000 |
| 60-Month Beta | 0.41 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.80 on 11/14/24 | 2.49 on 04/29/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/12/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.01 | 14.28 | 13.74 | 0.00 |